Medistim ASA
LSE:0OCD

Watchlist Manager
Medistim ASA Logo
Medistim ASA
LSE:0OCD
Watchlist
Price: 235.5 NOK 4.2% Market Closed
Market Cap: kr48.1m

Wall St Price Targets

0OCD Price Targets Summary
Medistim ASA

Wall Street analysts forecast 0OCD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 0OCD is 301.46 NOK with a low forecast of 298.51 NOK and a high forecast of 310.33 NOK.

Lowest Forecast
Price Target
298.51 NOK
27% Upside
Average Forecast
Price Target
301.46 NOK
28% Upside
Highest Forecast
Price Target
310.33 NOK
32% Upside
Medistim ASA Competitors:
Price Targets
PMT
PennyMac Mortgage Investment Trust
28% Upside
VIBHA
Vibhavadi Medical Center PCL
5% Upside

Revenue
Forecast

11% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
11% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 3 years is 9%.

Gross Profit
Forecast

12% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
12% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Medistim ASA

Operating Income
Forecast

16% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss
16% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Over the last 14 years, the compound annual growth rate for Operating Income has been 16%. The projected CAGR for the next 3 years is 8%.

Pre-Tax Income
Forecast

17% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
17% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Medistim ASA

Net Income
Forecast

18% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
18% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Over the last 14 years, the compound annual growth rate for Net Income has been 18%. The projected CAGR for the next 3 years is 4%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 0OCD's stock price target?
Price Target
301.46 NOK

According to Wall Street analysts, the average 1-year price target for 0OCD is 301.46 NOK with a low forecast of 298.51 NOK and a high forecast of 310.33 NOK.

What is the Revenue forecast for Medistim ASA?
Projected CAGR
9%

Over the last 14 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 3 years is 9%.

What is the Operating Income forecast for Medistim ASA?
Projected CAGR
8%

Over the last 14 years, the compound annual growth rate for Operating Income has been 16%. The projected CAGR for the next 3 years is 8%.

What is the Net Income forecast for Medistim ASA?
Projected CAGR
4%

Over the last 14 years, the compound annual growth rate for Net Income has been 18%. The projected CAGR for the next 3 years is 4%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett